Publication | Open Access
LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases
47
Citations
59
References
2018
Year
Lccc 1025Breast OncologyMedicinePathologyPhase Ii StudyBreast CancerCancer TreatmentRadiation OncologyOncologyCell BiologyEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1